NEO Stock Price, Chart, Stats & News

NeoGenomics, Inc.
Save
290.37M
Market cap
–
Current P/E
222.22x
Forward P/E
NEO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 42.16% |
Operating margin | -15.62% |
Pretax margin | -15.16% |
Net margin | -14.85% |
Effective tax rate | 2.03% |
ROA | -7.94% |
ROE | -12.64% |
D/E | 0.56x |
Interest coverage ratio | -30.27x |
NEO valuation
P/E | – |
P/S | 0.26x |
P/B | 0.22x |
P/CF | 35.37x |
P/FCF | -8.57x |
P/OCF | 35.37x |
PEG | -0.38x |
EV multiple | 3.26x |
About
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers.
Similar securities
Based on sector and market capitalization
Report issue










